the value of treating mgus and smoldering myeloma patients with novel immunotherapies
Published 2 years ago • 2.3K plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
2:30
mgus and its future in the treatment of myeloma
-
1:23
managing patients with multiple myeloma who have stopped treatment prior to relapse
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
2:56
novel drugs for myeloma thromboprophylaxis
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
1:02:06
interpreting mgus/smoldering myeloma labs- what to know and when to take action
-
3:12
how often should individuals diagnosed with mgus have their myeloma markers retested?
-
5:25
novel immunotherapies for multiple myeloma
-
2:42
the importance of better identifying individuals with mgus & the possibility of treating precursors
-
1:59
the rapid evolution of myeloma research & the importance of improving drug accessibility
-
2:10
using the innate immune system to treat mds & the value of novel immunotherapies
-
2:44
myeloma qol through induction and maintenance
-
2:15
novel immunotherapies for the treatment of multiple myeloma
-
5:16
genomic analysis of patients with mgus who progress to myeloma versus those who do not
-
2:30
a new era of treatment for multiple myeloma
-
0:54
immune-mediated mechanisms of progression in mgus and smouldering myeloma
-
11:29
progression and treatment of mgus-smm-mm & epigenetics
-
1:55
mgus progression to overt myeloma: the tumor microenvironment
-
3:41
emerging therapies for r/r myeloma
-
5:52
identifying mgus-like phenotype in multiple myeloma and light-chain amyloidosis
-
1:15
early prevention of myeloma: dara for high-risk mgus and low-risk smm